Browse studies

Find your next paid study

1 recruiting study matching your filters

A First in Human, Double-Blind, Placebo-Controlled, Randomized Evaluation of Single Ascending Doses of ATI-1013, a Human Monoclonal Antibody to Nicotine in Healthy Smokers

This study is a first-in-human clinical trial of drug ATI-1013, in healthy adult cigarette smokers. The main questions it aims to answer are to learn about the…

Thromboangiitis Obliterans (Buerger's Disease)

Estimated

~$10 – $8,750

Antidote Therapeutics, IncNCT07215923